Those prescribed the drug for obesity were more than seven times more likely to receive a NAION diagnosis than similar patients who didnt take semaglutide
doi:10.1007/s12016-011-8291-x [39] Karlsson F, Tremaroli V, Nielsen J, Bckhed F
With regular use, Semaglutide can lead to significant weight loss and can help reduce the risk of developing other health problems such as type 2 diabetes, cardiovascular disease, and other obesity-related conditions
Patients appear gaunt not only due to volume loss but also resulting from changes in the facial skin where there is a loss of collagen, elastin, and essential nutrients
doi:10.1016/j.neuron.2013.07.038 Kok BP, Galmozzi A, Littlejohn NK, et al